Page last updated: 2024-08-24

bmy 25067 and Breast Neoplasms

bmy 25067 has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blaxall, JR; Hamilton, JW; Ihnat, MA; La Ronde, N; Lariviere, JP; Pierre, KM; Turpie, BW; Warren, AJ	1

Other Studies

1 other study(ies) available for bmy 25067 and Breast Neoplasms

Article	Year
Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:8 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Survival; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Female; Humans; K562 Cells; Liver Neoplasms; Mitomycin; Mitomycins; Neuroblastoma; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Verapamil	1997

Article

Year

Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:8

Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Survival; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Female; Humans; K562 Cells; Liver Neoplasms; Mitomycin; Mitomycins; Neuroblastoma; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Verapamil

1997